Financials

NASDAQBLFS
Beta1.01
Shares Outstanding13.2M
Average Volume (10 days)322.5K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.47)
Sales (TTM)$0.54
Book Value (MRQ)$0.52
Cash Flow (TTM)($0.14)
Cash (MRQ)$0.18

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy2
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Andrew G. Hinson
997
Acquire
Oct 03, 2017
Raymond Wayne Cohen
3,325
Acquire
Oct 03, 2017
Joseph Schick
1,108
Acquire
Oct 03, 2017
Thomas Girschweiler
Director, Ten Percent Owner
887
Acquire
Oct 03, 2017
Andrew G. Hinson
2,354
Acquire
Jul 06, 2017

Recent SEC Filings

Insider Buy/Sell
Oct 03, 2017
Insider Buy/Sell
Oct 03, 2017
Insider Buy/Sell
Oct 03, 2017
Insider Buy/Sell
Oct 03, 2017
Quarterly Financials
Aug 11, 2017
Recent News
Oct 19, 2017

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media...

Oct 18, 2017

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, today...

Sep 19, 2017

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media...

View All


Print Friendly